Passer à la navigation principale
Passer à la recherche
Passer au contenu principal
Trier par
Keyphrases
Escherichia Coli Bacteremia
100%
Piperacillin-tazobactam
100%
Esbl
100%
Definitive Therapy
44%
Clinical Standards
22%
Extended-spectrum β-lactamase
22%
Ceftriaxone-resistant
22%
Laboratory Standards Institute
22%
Canada
11%
Antibiotics
11%
Pediatric
11%
Escherichia Coli
11%
McGill University
11%
Clinical Efficacy
11%
Infectious Diseases
11%
Withholding
11%
Bloodstream Infection
11%
Enterobacteriaceae
11%
β-lactamase Inhibitor
11%
In-hospital Mortality
11%
Increased Mortality
11%
Retrospective Observational Study
11%
Sequential Group
11%
Extended-spectrum beta-lactamase-producing Enterobacteriaceae
11%
Extended-spectrum beta-lactamase-producing Escherichia Coli
11%
Serious Infection
11%
Microbiology Laboratory
11%
Positive Blood Culture
11%
University Medical Centre
11%
Antimicrobial Susceptibility Testing
11%
Infectious Diseases Consultation
11%
Multidrug-resistant E. Coli
11%
Infection-immunology
11%
Medicine and Dentistry
Bloodstream Infection
100%
Escherichia coli
100%
Piperacillin/Tazobactam
100%
Infection
44%
Extended Spectrum Beta Lactamase
33%
Ceftriaxone
22%
Antibiogram
11%
Pediatrics
11%
Observational Study
11%
Enterobacteriaceae
11%
Beta Lactam
11%
β-Lactamase inhibitor
11%
Beta Lactamase Inhibitor
11%
Hospital Mortality
11%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
11%
Antibiotics
11%
Blood Culture
11%